Clinical trial

Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With…

NCT00004448 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed

Key facts

NCT number NCT00004448
Title Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy
Lead sponsor National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH
Collaborators Southwest Pediatric Nephrology Study Group
Status Completed
Phase Phase 2
Study type Interventional
Conditions IgA Glomerulonephritis
Intervention type Drug
Interventions omega-3 fatty acids, prednisone, Placebo
Enrollment 96
Start date Nov 1, 1997
Primary completion Aug 1, 2007
Completion Aug 1, 2007
First posted Oct 19, 1999
Last update posted May 4, 2025
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies